Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
blood plasma (1 trial)
coagulation factor viia (recombinant) (NovoSevenRT) (1 trial)
human factor ix complex (prothrombin complex concentrate) (Bebulin) (1 trial)
Hemorrhage (Phase 1)
Intracranial Hemorrhages (Phase 1)
Trials (1 total)
Trial APIs (3 total)